期刊文献+

骨组织工程材料RGD表面修饰的研究进展 被引量:1

原文传递
导出
摘要 目前用于骨组织工程的载体材料主要包括:金属、陶瓷、生物衍生材料、高分子合成材料以及复合材料,而各种材料都因其自身特性的限制,无法完全达到自体骨的功能,其中一个突出的问题就是无法形成优良的骨整合,主要原因是材料表面对成骨细胞缺乏有效的黏附能力,从而影响骨愈合过程。因此对材料进行必要的修饰,以提高表面生物活性,从而利于细胞的有效黏附,并促进其扩展、增殖和分化就成为了骨组织工程的一个研究热点。
出处 《中华骨科杂志》 CAS CSCD 北大核心 2008年第3期240-243,共4页 Chinese Journal of Orthopaedics
  • 相关文献

参考文献32

  • 1LeBaron RG, Athanasiou KA. Extracellular matrix cell adhesion peptides: functional applications in orthopedic materials. Tissue Eng, 2000, 6: 85-103.
  • 2Masaki C, Schneider GB, Zaharias R, et al. Effects of implant surface microtopography on osteoblast gene expression. Clin Oral Implants Res, 2005, 16: 650-656.
  • 3Marinucci L, Balloni S, Becchetti E, et al, Effect of titanium surface roughness on human osteoblast proliferation and gene expression in vitro. Int J Oral Maxillofac Implants, 2006, 21: 719-725,
  • 4Kim SS, Ahn KM, Park MS, et al. A poly (lactide-co-glycolide)/hydroxyapatite composite scaffold with enhanced osteoconductivity. J Biomed Mater Res A, 2007, 80: 206-215.
  • 5Zhang R, Ma PX. Biomimetic polymer/apatite composite scaffolds for mineralized tissue engineering. Macromol Biosci, 2004, 4:100-111.
  • 6Verrier S, Pallu S, Bareille R, et al. Function of linear and cyclic RGD-containing peptides in osteoprogenitor cells adhesion process. Biomaterials, 2002, 23: 585-596.
  • 7Durrieu MC, Pallu S, Guillemot F, et al. Grafting RGD containing peptides onto hydroxyapatite to promote osteoblastic cells adhesion. J Mater Sci Mater Med, 2004, 15: 779-786.
  • 8Cavalcanti-Adam EA, Shapiro IM, Composto R J, et al. RGD peptides immobilized on a mechanically deformable surface promote osteoblast differentiation. J Bone Miner Res, 2002, 17: 2130-2140.
  • 9张丽红,吕凯歌,潘可风,蒋欣泉,张秀丽,黄艳霞.RGD-PLGA/HA膜材料的细胞亲和性实验研究[J].口腔颌面外科杂志,2007,17(1):17-20. 被引量:4
  • 10Schaffner P, Dard MM. Structure and function of RGD peptides involved in bone biology. Cell Mol Life Sci, 2003, 60:119-132.

二级参考文献98

  • 1孔航,章燕,蒋欣泉,潘可风.兔骨髓基质细胞的体外成骨定向诱导培养[J].口腔颌面外科杂志,2006,16(1):11-15. 被引量:7
  • 2李德华.医用钛表面的微观改造[J].国外医学(生物医学工程分册),1997,20(1):24-27. 被引量:16
  • 3[4]Hersel U,Dahmen C,Kessler H.Biomaterials,2003,24(24):4385-4415.
  • 4[5]Pierschbacher MD,Ruoslahai E.Nature,1984,309(5963):30-33.
  • 5[6]Duong LT,Nakamura I,Lakkakorpi PT,et al.J BiolChem,2001,276(10):7484-7492.
  • 6[7]Clark EA,Brugge JS.Science,1995,268(5208):233-239.
  • 7[8]Faccio R,Novack DV,Zallone A,et al.J Cell Biol,2003,162(3):499-509.
  • 8[9]Zreiqat H,Ahuakin F,Howlett CR,et al.J Biomed Mater Res A,2003,64(1):105-113.
  • 9[10]Kantlehner M,Schaffner P,Finsinger D,et al.Chem biochem,2000,1(2):107-114.
  • 10[11]Porte-Durrieu MC,Guillemot F,Pallu S,et al.Biomaterials,2004,25(19):4837-4846.

共引文献42

同被引文献85

  • 1Reichert JC, Saifzadeh S, Wullschleger ME, et al. The challenge of establishing preclinical models for segmental bone defect research. Biomaterials. 2009;30(12):2149-2163.
  • 2Dimitriou R, Tsiridis E, Giarlnoudis PV. Current concepts of molecular aspects of bone healing. Injury. 2005;36(12): 1392-404.
  • 3Moreno L A, Valtuena J, Perez-Lopez F, et al. Health effects related to low vitamin D concentrations: beyond bone metabolism. Ann Nutr Metab. 2011 ;59(1):22-27.
  • 4Geuze RE, Theyse LF, Kempen DH, et al. A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a targe-animal model. Tissue Eng Part A. 2012;18(19-20):2052-2062.
  • 5Hernandez A, Reyes R, Sanchez E, et al. In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system. J Biomed Mater Res A. 2012; 100(9):2382-2391.
  • 6Park D J, Yoon C, Thomas N, et al. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers. Ann Surg Oncol. 2014;21 (4): 1130-1137.
  • 7Zellin G. Growth factors and bone regeneration. Implications of barrier membranes. Swed Dent J Suppl. 1998;129:7-65.
  • 8Gorskaya YF, Danilova TA, Mezentseva MY, et al. Effect of BMP-2 protein on the count and osteogenic properties of multipotent stromal cells and expression of cytokine genes in primary cultures of bone marrow and spleen cells from CBA mice immunized with bacterial antigens. Bull Exp Biol Med. 2013; 155(6):650-654.
  • 9Winn SR, Uludag H, Hollinger JO. Carrier systems for bone morphogenetic proteins. Clin Orthop Relat Res. 1999;(367 Suppl):S95-S106.
  • 10Suarez-Gonzalez D, Lee J S, Diggs A, et al. Controlled multiple growth factor delivery from bone tissue engineering scaffolds via designed affinity. Tissue Eng Part A. 2014; 20(15-16):2077-2087.

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部